Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-30

Clinical Trial Update: The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of the probiotic Bif195 (Bifidobacterium breve Bif195) for small intestinal Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bif195 (Bifidobacterium breve Bif195)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Crohn Disease | NA | Status: COMPLETED